ACTIVE SUBSTANCE / INN

NEOSTIGMINE METHYLSULFATE

Brand name(s): NEOSTIGMINE METHYLSULFATE, PREVDUO, BLOXIVERZ
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA213244
NDA216903
ACTIVE SUBSTANCE
Neostigmine Methylsulfate
REGULATORS
FDA
SPONSORS / MAH
EXELA PHARMA, EUGIA PHARMA, AZURITY
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NEOSTIGMINE METHYLSULFATEANDA213244EUGIA PHARMAPrescription
NEOSTIGMINE METHYLSULFATEANDA213244EUGIA PHARMADiscontinued
BLOXIVERZNDA204078EXELA PHARMAPrescription
BLOXIVERZNDA204078EXELA PHARMADiscontinued
PREVDUONDA216903AZURITYPrescription

FULL INTELLIGENCE ON NEOSTIGMINE METHYLSULFATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →